Cite
HARVARD Citation
Qi, W. et al. (2015). Bevacizumab increases the risk of infections in cancer patients: A systematic review and pooled analysis of 41 randomized controlled trials. Critical reviews in oncology/hematology. 94 (3), pp. 323-336. [Online].